LIMONENE First draft prepared by Dr K.B. Ekelman and Dr D. Benz US Food and Drug Administration Washington, DC, USA 1. EXPLANATION Limonene has not been previously evaluated by the Committee. The active isomer is designated as d-Limonene in this monograph. In the report (Annex 1, reference 101) it is designated as (+)-limonene. d-Limonene is a liquid with a pleasant, lemon-like odour and a fresh citrus taste. It is a natural constituent of a variety of foods and beverages and is especially prevalent in citrus fruits. Extracted d-limonene is used primarily as a lemon fragrance in soaps, detergents, creams, lotions and perfumes, and as a flavouring agent in foods, beverages and chewing gum (NTP, 1990). It is found in non-alcoholic beverages (31 ppm), ice cream and ices (68 ppm), candy (49 ppm), baked goods (120 ppm), gelatins and puddings (48-400 ppm), and chewing gum (2300 ppm) (NTP, 1990). Human exposure to d-limonene is through consumption of foods and beverages, both those in which it naturally occurs and those to which it has been added. 2. BIOLOGICAL DATA 2.1 Biochemical aspects 2.1.1 Absorption, distribution, and excretion d-Limonene was rapidly absorbed (43 min) through the intact, shaved abdominal skin of mice (Meyer & Meyer, 1959). Twelve Long-Evans male rats were administered single topical doses of 5 mg/kg bw 14C-limonene; the treated area was then occluded for 3 h (2 males) or 6 h (10 males). Following occlusion, the residual dose was removed and the treated area was re-occluded. Pairs of treated rats were killed at 3, 6, 24, 48, and 72 h; urine and faeces were collected from rats killed at 24, 48, and 72 h, and plasma and tissue samples were taken at all time points. Authors reported that peak concentrations of radioactivity in tissue samples were measured 3-6 h after dosing in the gastrointestinal tract (0.1-0.4% dose/g), livers and kidneys (0.08-0.2% dose/g), and thyroid and fat (0.02-0.06% dose/g); except for the gastrointestinal tract, concentrations of radioactivity in all tissues were appreciably lower at 24 h. After 6 h of exposure, 48% of the radioactivity was recovered in the skin; at the 24-72 h sampling times, 8-12% was excreted in urine, 1-3% was excreted in faeces, and 14-18% was expired in air. Total mean recovery of radioactivity was reported to be approximately 76%. Following oral administration, the highest concentration of d-limonene or its metabolites in rats was found in the serum fraction of blood after 2 h. The other major organs containing metabolites of d-limonene were the liver and kidney, with peaks 1-2 h after ingestion. After 48 h, negligible amounts of d-limonene metabolites remained in the body. Approximately 60% of d-limonene was excreted in the urine, 5% in the faeces, and 2% was expired (Igimi et al., 1974). Kodama et al. (1974) reported that 72% of d-limonene metabolites were excreted in male rabbit urine 72 h after oral administration, while 7% was found in the faeces. 2.1.2 Biotransformation Kodama et al. (1974) identified the metabolites of orally administered d-limonene (also known as p-mentha-1,8-diene) in male rabbit urine as p-mentha-1,8-dien-10-ol (M-I), p-menth-1-ene-8,9-diol (M-II), perillic acid (M-III), perillic acid 8,9-diol (M-IV), p-mentha-1,8-dien-10-yl-beta-D-glucopyranosiduronic acid (M-V) and 8-hydroxy-p-menth-1-en-9-yl-beta-D- glucopyranosiduronic acid (M-VI). The list of metabolites was expanded based on a study done with male rats, hamsters, guinea-pigs, rabbits, dogs and humans (Kodama et al., 1976b). Five additional metabolites of d-limonene were identified: 2-hydroxy-p-menth-8-en-7-oic acid (M-VII), perillylglycine (M-VIII), perillyl-beta-D-glucopyrano-siduronic acid (M-IX), p-mentha-1,8-dien-6-ol (M-X) and p-menth-1-ene-6,8,9-triol (M-XI). The major metabolite in rats and rabbits was identified as M-IV, while the major metabolite in hamsters was found to be M-IX. In dogs, the major metabolite was M-II, but in guinea pigs and humans, it was M-VI. The possible metabolic pathways used by the various species are shown in Figure 1 below.Wade et al. (1966) reported that dietary limonene gives rise to uroterpenol (M-II: p-menth-1-ene-8,9-diol) in the urine of humans. 2.1.3 Effects on enzymes and other biochemical parameters Groups of control (6 animals) and experimental (4 animals) male Wistar rats were administered single gavage doses of 0, 200, 400, 600, 800, or 1200 mg/kg bw d-limonene in 2% tragacanth solution in a total volume of 4 ml/kg. Authors reported that no effects were observed on liver triglycerides, microsomal proteins, cytochrome b5 and drug metabolizing enzymes. In the same experiment, male Wistar rats were treated with gavage doses of 0 or 400 mg/kg bw d-limonene in 2% tragacanth solution in a total volume of 4 ml/kg for 2, 3, 15 or 30 days; animals were killed 24 h following the last dose. Authors reported that, following repeated treatment for 30 days, relative liver weight and hepatic phospholipid content were slightly increased, and liver and serum cholesterol were decreased 49% and 8%, respectively. In addition, palmitic, linoleic and arachidonic acids were increased, and stearic acid was decreased in the liver; aminopyrine demethylase and aniline hydroxylase were increased 26% and 22%, respectively, and cytochrome P-450 and b5 were increased by 31% and 30%, respectively (Ariyoshi et al., 1975). d-Limonene was reported to enhance bile flow in Wistar rats and mongrel dogs in a dose-related manner, and to decrease the ratio of biliary bile salts and phospholipids to cholesterol (Kodama et al., 1976). d-Limonene was reported to be an effective gallstone solubilizer in animals and humans (Igimi et al., 1976; Schenk et al., 1980), and to have no effect on liver weights nor levels of serum lipids when fed to male Wistar rats at 0.5 and 1% in the diet (Imaizumi et al., 1985). d-Limonene was reported to significantly damage and increase permeability of membranes of human lung fibroblasts (Thelestam et al., 1980; Curvall et al., 1984). 2.2 Toxicological studies 2.2.1 Acute toxicity studies Table 1: Summary of acute toxicity studies with d-limonene Species Sex Route LD50 Reference Mouse M&F oral, in 6.3 ml/kg (M) Tsuji et juice, 7d 8.1 ml/kg (F) al., 1974 Mouse M&F ip, in 3.7 ml/kg (M) Tsuji et juice, 3d 3.6 ml/kg (F) al., 1974 Mouse M&F ip, in 0.7 ml/kg (M) Tsuji et juice, 10d 0.6 ml/kg (F) al., 1974 Mouse M&F sc, in >25.6 ml/kg (M) Tsuji et juice, 7d >25.6 ml/kg (F) al., 1974 Mouse M&F oral 5600 mg/kg (M) Tsuji et 6600 mg/kg (F) al., 1975a Mouse M&F ip 1300 mg/kg (M) Tsuji et 1300 mg/kg (F) al., 1975a Mouse M&F sc >41500 mg/kg (M) Tsuji et >41500 mg/kg (F) al., 1975a Rat M&F oral 4400 mg/kg (M) Tsuji et 5100 mg/kg (F) al., 1975a Rat M&F ip 3600 mg/kg (M) Tsuji et 4500 mg/kg (F) al., 1975a Rat M&F sc >20200 mg/kg (M) Tsuji et >20200 mg/kg (F) al., 1975a An oral dose of 3 ml d-limonene (in juice)/kg decreased spontaneous motor activities in rats and mice and potentiated hexobarbital-induced sleeping and hypothermia in mice. Authors also reported that nicotine-induced convulsion and death (but not maximum electroshock-, pentetrazol-, strychnine-, nor picrotoxin-induced convulsions) were inhibited by d-limonene in mice. Intravenous administration of > 0.005 mg/kg d-limonene lowered the blood pressure of rabbits and dogs, and > 0.1-0.3 mg/kg killed those animals. Oral administration of 3 ml/kg d-limonene did not decrease the blood pressure of rats, however. Authors also reported that isolated smooth muscles of the intestine, vas deferens, uterus, and peripheral vessel were constricted by d-limonene (Tsuji et al., 1974). Single high s.c. doses of d-limonene produced scratch behaviour and single high i.v. doses of d-limonene produced stretch behaviour in mice and rats (Tsuji et al., 1975a). 2.2.2 Short-term studies 2.2.2.1 Mice Groups of 5 B6C3F1 male and female mice were given daily gavage doses of 0, 413, 825, 1650, 3300 or 6600 mg d-limonene/kg bw in 10 ml/kg bw corn oil 5 days/week over a 16 day period (12 total dosings). All mice (5/5) exposed to 6600 mg/kg bw/day, 4/5 males and 5/5 females exposed to 3300 mg/kg bw/day, and 1/5 males and 1/5 females exposed to 1650 mg/kg bw/day died before the end of the study. The one female that died at the latter dose level was reported to have been killed by a gavage error. Authors concluded that no compound-related clinical signs were observed in mice that received 1650 mg d-limonene/kg bw and lived to the end of the study, and that no compound-related histopathologic effects were seen (NTP, 1990). Groups of 10 B6C3F1 mice of each sex were given daily gavage exposures of 0, 125, 250, 500, 1000 or 2000 mg d-limonene/kg bw in 10 ml/kg bw corn oil 5 days/week for 13 weeks. One male exposed to 2000 mg/kg bw/day, two females exposed to 2000 mg/kg bw/day, and one female exposed to 500 mg/kg bw/day, died during the course of the study. In addition, one female exposed to 125 mg/kg bw/day and five males (one each from the groups exposed to 250 and 1000 mg/kg bw/day, and three from the group exposed to 500 mg/kg bw/day) died prior to the end of the study, but their deaths were attributed by the authors to accidents related to the gavage procedure used. At the two highest dose levels, mice were seen with rough hair coats and decreased activity. An alveolar cell adenoma was observed in the lung of one female mouse that had received 2000 mg d-limonene/kg bw/day (NTP, 1990). 2.2.2.2 Rats Groups of 5 F344/N rats of each sex were given daily gavage doses of 0, 413, 825, 1650, 3300 or 6600 mg d-limonene/kg bw in 10 ml/kg bw corn oil 5 days/week over a 16 day period (12 total doses). All rats receiving 6600 mg d-limonene/kg bw/day as well as 5/5 male and 3/5 female rats that were exposed to 3300 mg/bw/day died. The authors reported that no clinical signs were seen in rats receiving 1650 mg d-limonene/kg bw/day or lower, and that no compound-related histopathologic effects were seen in any rats (NTP, 1990). Groups of 5 male Fischer-344 rats were given single daily gavage doses containing 75, 150 or 300 mg d-limonene/kg bw in corn oil (5 ml/kg bw) 5 days/week for 5 or 20 doses, primarily to follow the development of renal alterations. The authors reported that no signs of gross toxicity were observed nor was there any effect on weight gain or feed consumption over the course of this experiment. However, after only 5 days of exposure, liver and kidney weights showed a dose-related increase and there was a dose-related increase in the number and size of hyaline droplets and accumulation of alpha2u-globulin in the proximal convoluted tubule epithelial cells of the kidneys. In addition, after 20 doses, granular casts in the outer zone of the medulla and multiple cortical changes (classified as chronic nephrosis) were also seen in dose-related severity (Kanerva et al., 1987a). In a subacute study, groups of 5 male and female rats were exposed daily to 0, 277, 554, 1385 or 2770 mg d-limonene/kg bw orally for 30 days. A general decrease in food intake and a dose-related decrease in body weight were seen in groups of exposed males, but little or no effect on organ weights nor relative organ weights was observed. No significant changes were seen in urinalysis, haematology or biochemical values. The following tissues were examined histopathologically: adrenals, duodenum, heart, kidneys, liver, lungs, lymph nodes, pancreas, pituitary, spleen, stomach, testes/ovaries, thymus and thyroids. Authors reported that no significant changes were noted except that granular casts were seen in the kidneys of most exposed male rats (0/5, 3/5, 5/5, 5/5 or 4/5 animals exposed to 0, 277, 554, 1385 or 2770 mg/kg bw/day respectively) (Tsuji et al., 1975a). Groups of 10 F334/N rats of each sex were given daily gavage doses of 0, 150, 300, 600, 1200 or 2400 mg d-limonene/kg bw in 5 ml/kg bw corn oil 5 days/week for 13 weeks. Five male and nine female rats exposed to 2400 mg d-limonene/kg bw/day died during the course of the study. In all rats receiving 1200 or 2400 mg/kg bw/day, rough hair coats, lethargy and excessive lacrimation were observed. Authors reported that nephropathy was seen in all groups of male rats, with a dose-related increase in severity. The nephropathy was reported to be characterized by degeneration of epithelium in the convoluted tubules, granular casts within tubular lumens (primarily in the outer stripe of the outer medulla), and regeneration of the tubular epithelium. In all groups of male rats (including control animals), hyaline droplets were observed in the epithelium of proximal convoluted tubules in at least some animals. An attempt to determine by "blind" evaluation if the incidence of these droplets was dose-related was reported to have resulted in an equivocal conclusion. The slides containing the renal sections made from male rats exposed to d-limonene in this 13 week study were reviewed. They reported that hyaline droplet accumulation within the cytoplasm of proximal convoluted tubule (PCT) epithelial cells was uniform among all groups, including controls. However, chronic nephrosis, although seen in all animals (including control animals), appeared with a dose-related increase in severity. The authors attributed the uniformity of hyaline droplet accumulation to the fact that the animals were not exposed to d-limonene for 4-5 days before necropsy and examination, giving the animals time to rid themselves of some of the droplets, although more extensive damage to the kidneys (chronic nephrosis) was not repaired (Kanerva & Alden 1987). Chronic nephrosis consisted of cytoplasmic basophilia of the PCT epithelial cells, tubular hyperplasia or atrophy, fibrosis of Bowman's capsule and an interstitial fibrolymphocytic response. Atrophic tubules were characterized by thickened basement membranes and a decrease in tubular cross-sectional diameter due to a decrease in cell size, whereas tubules considered to be hyperplastic showed increases in cell size and number and an increase in cross-sectional diameter compared with the surrounding unaffected tubules. In addition, occasional foci of PCT epithelial cell necrosis/degeneration were observed in kidneys from all d-limonene-treated animals but not in control animals. All treated animals, but not controls, also showed a dose-related increase in the number of granular casts found in the outer stripe of the medulla. Granular casts were markedly dilated and had attenuated or non-existent epithelium. In addition, animals exposed to the highest dose level (2400 mg/kg bw/day) were reported to show multifocal hyaline casts and tubular dilation in the cortex and medulla (NTP, 1990). 2.2.3 Long-term/carcinogenicity studies 2.2.3.1 Mice To assess the pulmonary tumour carcinogenicity of d-limonene, groups of 15 male or female A/He mice were injected i.p. with d-limonene 3 times weekly for 8 weeks (4.8 or 24 g/kg bw total dose) and then necropsied 24 weeks after the first injection. No significant induction of lung tumours was seen (Stoner et al., 1973). Groups of 50 8-9 week old male B6C3F1 mice were given daily gavage doses of 0, 250, or 500 mg d-limonene/kg bw and groups of 50 8-9 week old female B6C3F1 mice were given 0, 500, or 1000 mg d-limonene/kg bw in 10 ml/kg bw corn oil 5 days/week for 103 weeks. Mice were observed twice a day and weighed weekly for the first 12 weeks, after which they were weighed monthly. Clinical signs were recorded at least monthly. Moribund animals were killed and a necropsy was performed on all available animals. The tissues of all mice that died during the study and animals with grossly visible lesions, as well as all animals in the control and high dose groups, were examined for histopathology. The authors reported that no clinical signs were associated with administration of the test chemical. The survival of male mice exposed to 250 mg d-limonene/kg bw/day was lower than that of controls at the end of the study (controls: 33/50; 250 mg/kg bw/day: 24/50; 500 mg/kg bw/day: 38/50). No other differences in survival were seen among exposed groups of either sex. Mean body weights of exposed and control male mice were generally comparable. Weights of female mice in the 1000 mg d-limonene/kg bw/day group, however, were 5-15% lower than control animals after week 28. Multinucleated liver hepatocytes and cells with cytomegaly occurred at increased incidence in male mice exposed to 500 mg d-limonene/kg bw/day (multinucleated hepatocytes: controls - 8/49; 250 mg/kg bw/day - 4/36 [incomplete sampling]; 500 mg/kg bw/day - 32/50) (hepatocytes with cytomegaly: controls - 23/49; 250 mg/kg bw/day - 11/36 [incomplete sampling]; 500 mg/kg bw/day - 38/50). The combined incidence of hepatocellular adenomas and carcinomas, however, did not differ significantly from their incidence in control mice (controls: 22/49; 250 mg/kg bw/day: 14/36 [incomplete sampling]; 500 mg/kg bw/day: 15/50). No significant differences were observed in female mice for any of these endpoints. The incidence of adenomas or the combined incidence of adenomas and carcinomas in the anterior pituitary gland of female mice exposed to 1000 mg d-limonene/kg bw/day were significantly lower than controls. The incidence of hyperplasia did not differ significantly from controls, however (hyperplasia: controls - 16/49; 500 mg/kg bw/day - 0/8 [incomplete sampling]; 1000 mg/kg bw/day - 17/48) (adenomas: controls - 12/49; 500 mg/kg bw/day - 5/8 [incomplete sampling]; 1000 mg/kg bw/day - 1/48) (combined adenoma and carcinoma: controls - 12/49; 500 mg/kg bw/day - 5/8 [incomplete sampling]; 500 mg/kg - 2/48) (NTP, 1990). 2.2.3.2 Rats Groups of fifty 7-8 week old male F344/N rats were given daily gavage doses of 0, 75, or 150 mg d-limonene/kg bw and groups of 50 7-8 week old female F344/N rats were given 0, 300, or 600 mg d-limonene/kg bw in 5 ml/kg bw corn oil 5 days/week for 103 weeks. Rats were observed twice a day; they were weighed weekly for the first 12 weeks, and monthly thereafter. Clinical signs were recorded at least monthly. Moribund animals were killed; necropsies were performed on all available animals. The tissues of all rats that died during the study, animals with grossly visible lesions, and all animals in the control and high dose groups were examined for histopathology. No compound-related clinical signs were reported. The survival of the female animals exposed to 600 mg/kg bw was lower than that of control animals after week 39, while the survival of male rats exposed. Mean body weights of male rats exposed to 150 mg/kg bw were generally 4%-7% lower than controls from week 28. Cataracts were observed at increased incidence in male rats exposed to 150 and female rats exposed to 300 or 600 mg d-limonene/kg bw/day, and retinal degeneration was seen in all dosed animals. The authors pointed out, however, that the rats of each sex that were exposed to their respective highest-dose levels were housed in the top rows of the cage racks, the animals exposed to the low-dose levels were below them, and the controls were housed in the lowest rows for all but the last 10 weeks of the study. Authors conclude that these effects were due to variations in the proximity of animals in different dose groups to the light source. Subcutaneous tissue fibromas in male rats occurred with a negative dose-response trend (controls: 8/50; 75 mg/kg bw/day: 2/50; 150 mg/kg bw/day: 3/50). However, the combined incidence of fibromas and fibrosarcomas was not significantly different when dosed males were compared to controls (controls: 8/50; 75 mg/kg bw/day: 4/50; 150 mg/kg bw/day: 3/50). Combined squamous cell papillomas or carcinomas in the skin of male rats showed a positive dose-response trend (controls: 0/50; 75 mg/kg bw/day: 0/50; 150 mg/kg bw/day: 3/50). However, the incidence of these neoplasms in dosed male rats was within the range of incidences for NTP historical control rats, and did not differ significantly from the incidence in control animals. The authors concluded that the positive dose-response trend was not related to d-limonene exposure. Mononuclear cell leukaemia occurred in male rats with a positive dose-response trend by the incidental tumour test (controls: 10/50; 75 mg/kg bw/day: 10/50; 150 mg/kg bw/day: 19/50). The incidences in dosed male rats were not significantly different from the incidences in controls, however. The authors concluded that the positive dose-response trend was not related to d-limonene administration. There was a significant positive dose-response trend in the incidence of interstitial cell tumours in the testes of male rats, and the incidences of these tumours in dosed groups were significantly higher than the incidences in control animals (control: 37/50; 75 mg/kg bw/day: 47/49; 150 mg/kg bw/day: 48/50). The authors argued, however, that since historically this type of tumour occurs in almost all aged F344 rats, this result should not be considered to be related to d-limonene exposure, but rather was an artifact caused by the low survival of the control animals in this experiment (see above). The incidence of uterine endometrial stromal polyps in females exposed to 300 mg/kg bw/day was increased when compared to controls. However, the incidence in the control animals was well below the NTP historical incidence of this tumour. For this reason, and because there was no positive dose-response trend, the authors argued that this was not a compound-related effect. d-Limonene exposure of male rats was associated with dose-related increases in the incidences of mineralization and epithelial hyperplasia in the kidneys (mineralization: controls - 7/50; 75 mg/kg bw/day - 43/50; 150 mg/kg bw/day - 48/50) (epithelial hyperplasia: controls - 0/50; 75 mg/kg bw/day - 35/50; 150 mg/kg bw/day - 43/50). The lesions consisted of linear deposits of mineral in the medulla (renal papilla) and focal hyperplasia in the transitional epithelium overlying the papilla. Hyperplasia was frequently located near the fornices of the renal pelvis and was occasionally bilateral. The severity of nephropathy, which occurs spontaneously in aged male rats, was also positively dose-related in this experiment (severity of nephropathy, rated on a scale from 0 [not present] to 4 [marked]: control mean - 1.5; 75 mg/kg bw/day mean - 1.8; 150 mg/kg bw/day mean - 2.2). This nephropathy was characterized by degeneration and atrophy of the tubular epithelium, dilation of tubules with formation of hyaline droplets and granular casts, regeneration of tubular epithelium, glomerulosclerosis, and interstitial inflammation and fibrosis. Kidney tubular cell hyperplasia and neoplasms were also increased in dosed male rats (hyperplasia: controls - 0/50; 75 mg/kg bw/day - 4/50; 150 mg/kg bw/day - 7/50) (adenomas: controls - 0/50; 75 mg/kg bw/day - 4/50; 150 mg/kg bw/day - 8/50) (adenocarcinomas: controls - 0/50; 75 mg/kg bw/day - 4/50; 150 mg/kg bw/day - 3/50) (combined adenomas and carcinomas: controls - 0/50; 75 mg/kg bw/day - 8/50; 150 mg/kg bw/day - 11/50). Incidences of tubular cell adenomas and the combined incidences of adenomas and adeno-carcinomas in male rats showed significant positive dose-response trends. High-dose males had a significantly higher incidence than control males of both categories of tumours, while low-dose males had a significantly higher incidence of the combined category than control males. These neoplasms are historically rare and none were seen in control males nor in any group of females. The authors stated that kidney tubular cell hyperplasia, adenomas, and adenocarcinomas were part of a morphologic spectrum. Proliferative lesions diagnosed as hyperplasia generally consisted of one to three adjacent cross-sections of enlarged tubules with stratification of the epithelium. In some lesions, the epithelial cells appeared to completely fill the lumen. The tubular cell neoplasms varied in diameter from less than 1 mm to 15 mm. They exhibited varied patterns of growth and were either solid, cystic, or papillary. The solid and cystic neoplasms showed little evidence of tubular structures and the cells were arranged in solid sheets or small solid nests separated by a delicate vascular stroma. Some neoplasms were reported to consist of layers of epithelium lining a fibrous connective tissue stroma and were arranged in complex branching papillary formations. The neoplasms were classified as adenocarcinomas primarily if they exhibited cellular pleomorphism and anaplasia, or if they were larger than 10 mm (NTP, 1990). 2.2.3.3 Dogs Groups of 3 male or female Japanese beagle dogs were exposed orally to 0, 0.4, 1.2 or 3.6 ml d-limonene/kg bw daily for 6 months. Dose-related occurrences of frequent vomiting and nausea were seen in some animals. At doses of at least 1.2 ml/kg bw/day for females and 3.6 ml/kg bw/day for males, a decrease in body weight gain was noted compared to controls, but little or no effect on food intake, organ weights or relative organ weights was reported. No significant changes were seen in urinalysis, haematology nor biochemical values, except that in animals at the 3.6 ml/kg bw/day level, total cholesterol and blood sugar were lowered. The following tissues were examined histopathologically: adrenals, bile duct, duodenum, heart, kidneys, liver, lungs, pancreas, pituitary, rectum, spleen, stomach, testes/ovaries, thymus and thyroids. No significant changes were noted except that granular casts were seen in the kidneys of all male dogs exposed to 3.6 ml/kg bw/day and all females exposed to 0.4 ml/kg bw/day or more (1/3, 1/3, 2/3 or 3/3 for males; 1/3, 2/2, 3/3 or 3/3 for females exposed to 0, 0.4, 1.2 or 3.6 ml/kg bw, respectively) (Tsuji et al., 1975b). In a more recent study, groups of five male and female beagle dogs were gavaged twice daily for six months with 0, 0.12, or 1.2 ml/kg bw/day (0, 10, or 1000 mg/kg bw/day) d-limonene. The highest dose was reported to be near the maximum tolerated dose for emesis. The authors stated that food consumption and body weight were not affected by treatment. Although there was a positive dose-related trend for absolute and relative female kidney weights and for relative male kidney weight, authors reported that there were no histo-pathological findings in the kidneys that could be associated with the organ weight changes. In addition, there was no hyaline droplet accumulation nor other indication of nephropathy such as those associated with d-limonene consumption in male rats (Webb et al., 1990) 2.2.3.4 Cocarcinogenicity/tumour promotion studies Two publications have reported the results of experiments in which 0.25 ml oil of sweet orange, composed of > 90% d-limonene, was applied to the skin of 10 male and 10 female "101" mice weekly for 42 weeks, starting 3 weeks after an application of 300 µg 7,12-dimethyl-1,2-benzanthracene (DMBA) in 0.2 ml acetone. While no effects in the area of the treated skin were seen in mice exposed to d-limonene or to DMBA alone, mice exposed to DMBA followed by exposure to d-limonene began to develop papillomas during the twelfth week of d-limonene exposure. After 33 weeks of treatment, 13/18 treated mice showed a total of 39 papillomas. No malignant tumours were seen in the exposed area, however. In a second study, mice were exposed to d-limonene following exposure to: 1) 4 skin applications of 60 mg urethane in 0.3 ml acetone at 3 day intervals, or 2) 4 i.p. injections of 16 mg urethane in 0.1 ml distilled water at 3 day intervals. Papillomas appeared on 3/13 mice in group 1 and 2/13 mice in group 2 by the fourteenth week of exposure. In a final experiment, the terpene fraction of oil of sweet orange (containing d-limonene) was isolated and tested with DMBA as described for the first experiment. Papillomas in mice exposed to both DMBA and the terpene fraction of oil of sweet orange began to appear in the eleventh week of treatment and were visible in 8/15 mice by the thirty-third week of treatment. Although pure d-limonene was not tested in these experiments, the authors concluded that the promoting effects seen were probably caused by this chemical since it was the primary constituent of the test agent (Roe, 1959, Roe & Peirce, 1960). A group of 23 male and female albino mice were given single doses of 50 µg benzo(a)pyrene (BAP) by stomach tube followed by 40 weekly doses of 0.05 ml d-limonene; seventeen male and female mice received BAP only, 15 male and female mice received d-limonene only and 18 male and female mice served as untreated controls. While no tumours of the forestomach epithelium were seen in control animals, 2 animals treated with BAP alone (12%), 2 animals treated with d-limonene alone (13%), and 5 animals treated with both BAP and d-limonene (22%), developed 0, 2, 3, and 8 tumours, respectively, although none was judged to be a carcinoma. The authors concluded that although d-limonene was weakly carcinogenic for mouse forestomach epithelium it did not increase the tumour yield caused by pretreatment with BAP and, therefore, was not a promoter (Field & Roe, 1965). Cells of embryos taken from F344 rats were infected with Rauscher murine leukaemia virus and then treated with 0.05 µg/ml 3-methylcholanthrene (3-MCA) followed by 15 µg/ml d-limonene. Following treatment with 3-MCA and d-limonene, colony formation in semisolid medium was observed and was considered to denote cell transformation. Authors reported that d-limonene alone failed to transform cells and 3-MCA alone was only effective at concentrations exceeding 0.2 µg/ml (Roe, 1959; Roe & Peirce, 1960; Traul et al., 1981)). Elegbede and co-workers attempted to repeat the 1960 study of Roe and Peirce (see above) using purified d-limonene as well as oil of sweet orange. The skin of groups of 24 female CD-1 mice were treated once with 51.2 µg DMBA in 0.2 ml acetone followed 14 days later by twice weekly applications of 0.1 ml d-limonene or oil of sweet orange mixed with 0.1 ml acetone. Other groups of mice were similarly initiated with DMBA, but beginning 7 days later were given a diet containing 1% d-limonene or oil of sweet orange. In all cases, administration of d-limonene or oil of sweet orange continued for 40 weeks after DMBA treatment. Topical (but not ingested) d-limonene was found to slightly increase the number of tumours induced by DMBA alone, the increase becoming significant only after 34 weeks of treatment. When oil of sweet orange (95% d-limonene content) was applied to the skin, authors reported that a promoting effect was seen after 7 weeks of treatment; promotion was not reported, however, when oil of sweet orange was incorporated into the diet. The authors concluded that a component of orange oil other than d-limonene was responsible for the promoting activity observed and that the very small promoting activity seen with d-limonene may be due to its contamination by this unidentified component (Elegbede et al., 1986b). 2.2.3.5 Anticarcinogenicity studies A group of 50 male C57Bl/6J mice were injected s.c. with 25 µg dibenzpyrene (DBP) followed 24 h later by an injection of 0.15 ml d-limonene. After 34 weeks of observation, the authors reported that d-limonene significantly delayed the appearance of lung adenomas induced by DBP and reduced the total number of tumours seen. At 30 weeks post-DBP exposure without subsequent exposure to d-limonene, lung adenomas were seen in approximately 70% of the animals; with exposure to d-limonene, tumours were seen in approximately 30% of the animals. In a second experiment reported in the same paper, a group of 50 female A/J mice were injected s.c. with DBP followed by 16 weekly injections into the tail vein of 1% v/v suspensions of 1 mg of d-limonene. The incidence of lung adenomas was reduced from 75% of animals exposed to DBP alone to 40% of animals exposed to DBP and injected with d-limonene. Control incidence of lung adenomas in this experiment was 27%. Treatment of mice with d-limonene alone reduced this background incidence to approximately 7% (Homburger et al., 1971). Simultaneously, 5 µg of BAP and 10 mg d-limonene were applied to the skin of groups of 50 female ICR/Ha Swiss mice three times a week for 440 days. d-Limonene was found to partially inhibit BAP carcinogenicity (Van Duuren & Goldschmidt, 1976). Female Sprague-Dawley rats were fed diets containing 0, 1000, or 10 000 ppm d-limonene for 1 wk, at which time they were given a single gavage dose of 65 mg DMBA/kg bw. The d-limonene-containing diet was then continued for 27 weeks. Authors reported that d-limonene delayed the appearance of DMBA-induced mammary tumours in a dose-related manner, reduced the incidence of tumours, and caused increased regression of tumours that did appear (Elegbede et al., 1984a,b). Female (W/Fu x F344)F2 rats were fed a diet containing 10% d-limonene for 80 days beginning after the first appearance of tumours induced by intubation of rats with 130 mg DMBA/kg bw. Significant tumour regressive action by d-limonene was observed, and the development of subsequent tumours was also reduced significantly (Elegbede et al., 1986a). Following initiation with DMBA (single gavage dose of 65 mg/kg in sesame oil), groups of female Sprague-Dawley rats were (1) fed a basal cereal diet one week before and 24 weeks following initiation with DMBA (controls), (2) fed a diet containing 5% d-limonene one week before and one week after treatment with DMBA, then fed the control diet for 24 weeks (initiation group), or (3) fed the control diet for one week before and one week following DMBA initiation, then fed the 5% d-limonene diet for 24 weeks (promotion/progression group). d-Limonene was reported to be effective in reducing the average number of rat mammary carcinomas in DMBA-initiated rats when fed during the initiation phase or during the initiation/progression phase of carcinogenesis. Time to appearance of the first tumour was extended only when d-limonene was fed during the initiation phase, however. Authors concluded that these effects could not be attributed to changes in mammary-relevant endocrine functions (serum levels of prolactin and duration of estrus cycle) (Elson et al., 1988). Female Wistar-Furth rats were (1) placed on diets containing 5% d-limonene or 5% orange oil (source of d-limonene) for 2 weeks prior to initiation with nitrosomethylurea (NMU; single i.v. dose of 50 mg/kg bw), then continued on these diets for 23 weeks; (2) fed diets containing 5% d-limonene for two weeks before and one week following initiation with NMU, then fed a basal diet for 22 weeks (initiation group); or (3) fed basal diets prior to and for 1 week following initiation with NMU, then fed diets containing 5% d-limonene for 22 weeks (promotion/progression group). Both orange oil and d-limonene decreased mammary tumour incidence (controls: 80%; d-limonene: 45%; orange oil: 47%) and the average number of mammary tumours per rat (controls: 1.8; d-limonene: 0.4; orange oil: 0.8) when present in the diet for two weeks before and 23 weeks after NMU administration. d-Limonene decreased tumour incidence and decreased the numbers of tumours per rat (by approximately 50%) when fed during the promotion/progression experiment but not the during the initiation experiment (Maltzman et al., 1989). 2.2.3.6 Studies on the mechanism of d-limonene carcinogenicity This section discusses (1) spontaneously occurring nephropathy in mature male rats and (2) the current proposed mechanism of carcinogenicity of d-limonene and other chemicals/mixtures that exacerbate this condition and lead to alpha2u-globulin-associated male rat nephropathy. (1) Mature male rat nephropathy Normal male rats at least 30 days old exhibited marked increased protein excretion in their urine not seen in younger males nor in females of any age. This proteinuria reached a maximum level of approximately 2.5-3 times that seen in females at 90 days of age. Microscopically, the authors also observed intracellular droplets in the epithelial cells of the upper two-thirds of the proximal convoluted tubules of kidneys of male rats at least 60 days old. The occurrence of these hyaline droplets consisted of a few groups of small droplets in occasional cells in 60 day old animals. The number of cells having droplets and the number and size of droplets per cell increased with age; from 90 days of age most proximal tubule cells contained them. In contrast, at 120 and 180 days of age, only a small number of females showed occasional droplets in a few cells of the proximal tubules. These authors further demonstrated the sex-relatedness of this phenomenon by castrating male rats at 30 days of age and injecting female rats with 5 mg testosterone every other day from 50 days of age. When examined at 120 days of age, the castrated male rats showed proteinuria at a level equal to control females and hyaline droplets were only seen in 4/20 animals. Testosterone-treated females, on the other hand, had proteinuria at a level approximately midway between control males and females. No hyaline droplets were seen in the proximal tubule cells of these females, however, showing that the addition of testosterone alone was insufficient to cause them to appear (Logothetopoulos & Weinbren, 1955). Numerous authors have since reported detailed descriptions of spontaneously occurring nephropathy in mature male rats which is a consequence of this hyaline droplet accumulation. The sequence of events appears to be that: (1) protein accumulates in the lysosomes in the cytoplasm of epithelial cells of the P2 segment of the proximal convoluted tubules in the kidney cortex; (2) the accumulated material becomes so abundant that it crystallizes, forming the microscopically visible hyaline droplets; (3) the continued build-up of material eventually leads to the death of epithelial cells with a concomitant thinning of the epithelial layer (although some regeneration is usually seen); and (4) the dead cell debris becomes lodged in the outer strip of the outer medulla where the tubules narrow, forming granular casts and causing tubule dilation with pressure necrosis of the cells of the tubule walls. There is also an increase in the relative weight of the kidneys accompanying this phenomenon. A steadily increasing number of agents have been identified that appear to exacerbate this hyaline droplet formation and its consequences in mature male rats. With some, noticeable changes occur within days of exposure. These agents include complex mixtures of hydrocarbons such as mineral spirits (Carpenter et al., 1975a; Phillips & Cockrell, 1984), "60" solvent (Carpenter et al., 1975b), "high naphthenic solvent" (Carpenter et al., 1977), the petroleum-derived or shale-derived jet fuel JP-5 (MacEwen & Vernot, 1978a; Parker et al., 1981; Bruner, 1984; MacNaughton & Uddin, 1984), petroleum-derived and shale-derived diesel fuel marine (DFM), the jet fuels JP-4, JP-TS and JP-7, and the missile propellants JP-10 and RJ-5 (Bruner, 1984; MacNaughton & Uddin, 1984), C/10-C/11 isoparaffin (Phillips & Egan, 1984; Phillips & Cockrell, 1984), five petroleum naphtha mixtures (Halder et al., 1984) and unleaded gasoline (MacFarland et al., 1984; Busey & Cockrell, 1984; Halder et al., 1984; Kitchen, 1984; Garg et al., 1988a,b, 1989; Short & Swenberg, 1988; Short et al., 1989a). Also included on the list are the individual chemicals decahydro-naphthalene (decalin, MacEwen & Vernot, 1978b; Gaworski et al., 1980, 1981; Bruner, 1984; Alden et al., 1984; Olson et al., 1986; Stone et al., 1987a,b; Kanerva et al., 1987b,c; Read, 1988), pentachloroethane (NTP, 1983; Goldsworthy et al., 1988), 1,4-dichlorobenzene (NTP, 1987a; Charbonneau et al., 1989), perchloroethylene (Goldsworthy et al., 1988), dimethyl methylphosphonate (NTP, 1987b), 2,2,4-trimethylpentane (Stonard et al., 1986; Short et al., 1987; Charbonneau et al., 1987; Lock et al., 1987; Loury et al., 1987; Short et al., 1989a), the chemically unrelated agents 3-methylamino-1-(3-trifluoromethyl-phenyl)-2-pyrazoline, cis/trans-2-(4'-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone and 2,3,5,6-tetrahycro-6-phenylimidazo-(2,1-b) thiazole (Read et al., 1988) and d-limonene (Kanerva et al., 1987a; NTP, 1990). There is no obvious common structure among the specifically identified chemicals that cause an increased accumulation of hyaline droplets in mature male rat kidneys. And there are examples of agents that do have similar mixtures/structures to those listed above that do not cause this phenomenon. These include "70" solvent (Carpenter et al., 1975c), two other petroleum naphtha mixtures (Halder et al., 1984), 1,2-dichlorobenzene (Charbonneau et al., 1989) and an analog of d-limonene, 4-vinylcyclohexene (NTP, 1986). Recently, however, Miller et al. (1989) reported that they have identified correlations between structure and binding affinity to alpha2u-globulin, but no specific details were given in their published report. While exposure to unleaded gasoline for 72 h has been shown to cause effects that are reversible (Garg et al., 1988a), with chronic exposure to several of these mixtures/chemicals the kidney nephrosis has been reported to progress to hyperplasia, adenoma and even adenocarcinoma (MacFarland et al., 1984; Kitchen, 1984; MacNaughton & Uddin, 1984; NTP, 1987a,b,c; NTP, 1990). (2) Mechanism for alpha2u-globulin-associated male rat nephropathy The mechanism proposed for alpha2u-globulin-associated male rat nephrosis has recently been thoroughly reviewed by the US Environmental Protection Agency (US EPA, 1991). Their review incorporated the results of many studies, including Charbonneau & Swenberg (1988), Swenberg et al. (1989), Flamm & Lehman-McKeeman (1991), Lehman-McKeeman et al. (1989), Lehman-McKeeman et al. (1990a,b), Short et al. (1987), Short et al. (1989a,b), Dietrich & Swenberg (1991), Murty et al. (1988), Ridder et al. (1990), and Webb et al. (1989). The review concluded that: "Of the eight model substances tested in chronic animal bioassays (decalin, dimethyl methyl phosphonate, JP-4 jet fuel, JP-5 shale-derived jet fuel, d-limonene, methyl isobutyl ketone, pentachloroethane, and unleaded gasoline), all invoked a specific type of protein droplet nephropathy in male rats and also produced renal tumours in male rats but not in other species tested. It has been proposed that such renal tumours are the end product in the following sequence of functional changes in the epithelial cells of proximal tubules: * Excessive accumulation of hyaline droplets in proximal tubules, representing lysosomal overload, cell loss, and regenerative cellular proliferation. * Cell debris in the form of granular casts accumulates at the 'corticomedullary' junction with associated dilation of the affected tubule segment and more distally, mineralization of tubules within the renal medulla. * Single-cell necrosis accompanied by compensatory cell proliferation and exacerbation of the chronic progressive nephropathy characteristically found in aging rats occurs. * Renal tubule hyperplasia and neoplasia develop subsequently. According to this hypothesis, the increased proliferative response caused by the chemically induced cytotoxicity results in clonal expansion of spontaneously initiated renal tubule cells and increased incidence of renal tumour formation (Trump et al., 1984a; Alden, 1989; Swenberg et al., 1989). This line of reasoning leads supporters of the hypothesis to conclude that the acute and chronic renal effects induced in male rats by such chemicals will be unlikely to occur in any species not producing alpha2u-globulin, or a very closely related protein, in the large quantities typically seen in the male rat (Alden, 1989; Borghoff et al., 1990; Green et al., 1990; Olson et al., 1990; Flamm & Lehman-McKeeman, 1991; Swenberg, 1991)." The following paragraphs summarize some of the data that support this hypothesis: Contents and catabolism of hyaline droplets/ phagolysosomes The composition of the hyaline droplet inclusions has been identified by Kanerva et al. (1987c) using two-dimensional gel electrophoresis and immunological binding as being four species of the low molecular weight protein alpha2u-globulin. As expected, alpha2u-globulin was found to be absent in immature male rats and female rats of all ages. It was present, however, in female rats that had been ovariectomized and repeatedly injected with testosterone. More recently, groups have confirmed that alpha2u-globulin is the major constituent of the renal phagolysosomal inclusions in male rats exposed to unleaded gasoline (Garg et al., 1988b), and perchloroethylene and penta-chloroethane (Goldsworthy et al., 1988). Finally, Dietrich and Swenberg (1991) reported that male NCI-Black-Reiter rats, which do not produce alpha2u-globulin, are not susceptible to nephropathy produced by 2,2,4-trimethylpentane, 1,4-dichloro-benzene, isophorone, PS-6 unleaded gasoline, or d-limonene. A sex-specific protein has been identified in human urine (Bernard et al., 1989), but the concentration (up to 108 µg/l) is about 10 000 times less than that of alpha2u-globulin in male rats (about 40 mg/24 h) (Roy & Neuhaus, 1967). Therefore assuming that the protein in human urine shows the same binding characteristics as alpha2u-globulin, it is reasonable to conclude that humans would be comparably less sensitive than the male rat. Alpha2u-globulin is synthesized in the liver of rats of both sexes. This protein is filtered by the kidney glomeruli and reabsorbed by the epithelial cells of the proximal convoluted tubules by the formation of phagosomes at the lumenal surface. Normally, the phagosomes then combine with cellular lysosomes and the protein is degraded. In mature male rats, however, this catabolism is slowed in some way under hormonal influence leading to the intracellular accumulation of the protein which becomes manifested as hyaline droplets. The degradation is slowed even more by exposure to at least some of the agents listed in the previous section (Stonard et al., 1986; Short et al., 1987; Kanerva et al., 1987c; Charbonneau et al., 1987). A time- and dose-dependent progressive increase in the number and size, and alterations in the morphology of phagolysosomes in proximal convoluted tubule epithelial cells have been demonstrated with exposure to unleaded gasoline (Garg et al,. 1989). The ability of unleaded gasoline to induce these effects declines with the age of the male rat, in proportion to the declining production of alpha2u-globulin (Murty et al., 1988). Binding of chemicals to alpha2u-globulin 1,4-Dichlorobenzene as well as its major metabolite, 2,5-dichlorophenol, were both found to be reversibly bound (and 1,4-dichlorobenzene also covalently bound) to alpha2u-globulin in the kidneys of treated male rats (Charbonneau et al., 1989). Similarly, two groups have attempted to identify the specific binding between one of these agents (2,2,4-tri-methylpentane) and alpha2u-globulin. Loury et al. (1987) reported that no covalent binding could be found, nor did there appear to be formation of a Schiff base. Lock et al. (1987), however, detected reversible binding of the metabolite 2,4,4-trimethyl-2-pentanol to alpha2u-globulin. This specific metabolite was found in liver cells of male rats only. Likewise with decalin, an alcohol metabolite has been identified that is unique to male rats (Olson et al., 1986). While both male and female rats synthesize cis,cis-2-decalol and trans,cis-2-decalol from cis-decalin in their livers, cis,cis-1-decalol was found only in males and cis,trans-1-decalol was produced in much higher concentrations than in females. In similar fashion, with trans-decalin as the substrate trans,trans-1-decalol was seen only in livers of male rats. When kidneys were examined, 2-decalone (cis or trans, depending on the original substrate) was found in the males while no decalin metabolites whatever were seen in female kidneys. Whether these unique male decalin metabolites react with alpha2u-globulin has not yet been tested. More recently, Lehman-McKeeman et al. (1989) have reported that d-limonene and d-limonene-1,2-oxide, a major metabolite of d-limonene, were found reversibly bound to alpha2u-globulin (identified by amino acid sequencing) in the kidneys of treated male, but not female, rats. Inhibition of alpha2u-globulin catabolism Charbonneau et al. (1988) reported that alpha2u-globulin bound in kidney cytosol was not digested by purified proteases or proteinase. Treating rats with leupeptin, an inhibitor of cathepsin B, a major lysosomal peptidase, mimics the ability of unleaded gasoline to cause the accumulation of alpha2u-globulin in kidney phagolysosomes. Authors concluded that the mechanism of nephrotoxicity involves inhibition of renal phagolysosomal proteolysis (Olsen et al., 1988). Induction of cell proliferation Short et al. (1989a) have shown that proliferation of epithelial cells in the P2 proximal tubule segment in male rats is associated with exposure of the animals to either 2,2,4-trimethylpentane or unleaded gasoline. They noted that this proliferation closely paralleled the extent and severity of detectable alpha2u-globulin in the same cells. The authors speculated that this proliferation leads to the nephrocarcinogenic effects caused by these agents. Proliferation was also noted by Charbonneau et al. (1989) in male rats treated with 1,4-dichlorobenzene. Short et al. (1989b) observed increased numbers of atypical cell foci and renal cell tumours in male, but not female, rats initiated with N-ethyl-N-hydroxyethylnitrosamine and subsequently exposed to unleaded gasoline or 2,2,4-trimethylpentane. The extent of the promotion was reported to be dose-related and to parallel the effects of these compounds on chronic cell proliferation. 2.2.4 Reproduction studies No information available. 2.2.5 Special studies on embryotoxicity d-Limonene was reported to increase the number of abnormal chick embryos to approximately 50% when a single dose (25 µM/embryo) in olive oil was injected suprablastodermically (Abramovici & Rachmuth-Roizman, 1983). Pregnant mice were given oral doses of 0, 591, or 2363 mg/kg bw d-limonene from days 7 through 12 of gestation. Authors reported significant decreases in body weight gain of dams in the high-dose group; fetuses of dams exposed to the high-dose showed increased incidences of lumbar rib, fused rib, delayed ossification, and decreased body weight gain relative to fetuses of control dams (Kodama et al., 1977a). Pregnant Japanese white rabbits were given oral doses of 0, 250, 500, or 1000 mg/kg bw d-limonene from day 6 to day 18 of gestation. Significant decreases in body weight gain in dams given 250 or 500 mg/kg bw/day d-limonene were observed, and survival in dams given 1000 mg/kg bw/day was significantly reduced (40% survival). From examination of the fetuses, authors concluded that d-limonene was not teratogenic in rabbits (Kodama et al., 1977b). 2.2.6 Special studies on genotoxicity Table 2: Genotoxicity data on d-limonene Test Test Concentration System Object of d-limonene Results Reference Ames test S. typhimurium .03-3 µmol/plate neg Florin et (+&-activ) TA98, TA100, al., 1980 TA1535, TA1537 Yeast S. cerevisiae .1-100 mM/5x107 (1) Fahrig, (-activ) MP1 strain cells 1984 Mammalian Mouse embryo 0-215 mg/kg (2) Fahrig, (-activ) system 1984 Ames test S. typhimurium 0-20 µM/plate neg Watabe (+&-activ) TA1535, TA100, et al., TA1537, TA1538, 1980 TA98 Ames test S. typhimurium 0-3333 µg/plate neg Haworth (+&-activ) TA98, TA100, et al., TA1535, TA1537 1983 Ames test S. typhimurium 0-3333 µg/plate neg NTP, (+&-activ) TA100, TA1535, 1990 TA1537, TA98 Mammalian Mouse L5178Y neg NTP, (+&-activ) cells in vitro 1990 Sister Chinese hamster 0-162 µg/ml neg NTP, chromatid ovary cells 1990 exchange in vitro (+&-activ) Chromosomal Chinese hamster 0-500 µg/ml (3) neg NTP, aberrations ovary cells 0-100 µg/ml (4) neg 1990 (+&-activ) in vitro Table 2 cont'd Test Test Concentration System Object of d-limonene Results Reference Ames test S. typhimurium 150 mg/plate neg Heck et (+&-activ) TA1535, TA1537, al., 1989 TA1538, TA98, TA100 Mammalian Mouse L5178Y 100 µg/ml neg Heck et (+&-activ) cells in vitro al., 1989 (1) Author reported that results indicated that d-limonene was a co-recombinant and an anti-mutagen. (2) Author reported that results indicated that d-limonene is inactive when given alone, but reduces the mutagenic effect of ethylnitrosourea when the two are co-administered. (3) Activated: addition of S9 from the livers of Aroclor 1254-induced male Sprague Dawley rats. (4) Not activated 2.2.7 Special studies on immune responses Limonene has been identified as a primary skin irritant in humans (Pirila et al., 1964; Klecak et al., 1977), rabbits (research Institute for the Development of Fragrance Materials, Inc., 1984; Research Institute for Fragrance Materials Inc., 1985), guinea-pigs (Klecak et al., 1977), and mice (Gad et al., 1986). d-Limonene was reported both to elicit (De Groot et al., 1985) and not to elicit (Greif, 1967) allergic reactions in human skin and to elicit allergic reactions in mouse skin (Gad et al., 1986). d-Limonene was reported to eliminate human skin sensitization to several aldehydes when they were co-administered with d-limonene (Opdyke, 1975), and d-limonene was reported to reduce the sensitivity and delayed hypersensitivity of guinea-pig skin to citral (Hanau et al., 1983; Barbier & Benezra, 1983). Gozsy and Kato (1957) reported that local endothelial phagocytosis is induced in rat skin by d-limonene, and that d-limonene increases phagocytosis in guinea-pig skin in vivo and in mouse skin in vitro (Gozsy & Kato, 1958) and increases capillary permeability in the guinea-pig (Kato & Gozsy, 1958). Male BALB/c mice were treated intragastrically with 0, 0.002, 0.008, 0.033, 0.133, 0.531 or 2.125 mg/ml d-limonene daily. After 8 weeks, but not after 4 weeks, the mitogenic responses of spleen cells taken from the treated animals and exposed in vitro to concanavalin A and phytohaemagglutinin, which stimulate T-cells, and lipopolysaccharide, which affects B-cells, were found to be suppressed by the d-limonene treatment. Other animals in groups of 10 were given these same doses of d-limonene daily for 7 days prior to, or 8 days following, immunization with keyhole limpet haemocyanin (KLH). Primary effects on T- and B-cell responses were determined 10 days later. Secondary effects were determined by reinoculating the animals with KLH 21 days after the first inoculation and then assaying on day 24. The primary and secondary responses were reported to be suppressed by d-limonene if the animals were exposed to KLH first, but stimulated in treated mice if exposed to KLH after d-limonene exposure. Histopathological examination of secondary lymphoreticular tissue taken from animals exposed to d-limonene showed significant secondary follicle development and prominent lymphoid nodules and aggregates in the pancreas and intestinal mucosa, which were evident in animals which had received the highest dose of d-limonene (Evans et al., 1987). 2.3 Observations in humans Numerous prospective and retrospective cohort epidemiological studies have been done on populations of refinery, chemical plant, and service station workers, exposed to mixtures of chemicals that have been associated with male rat alpha2u-globulin nephropathy (Hanis et al., 1979; Schottenfeld et al., 1981; Hanis et al., 1982; Thomas et al., 1982; Austin & Schnatter, 1983; Higginson et al., 1984; Raabe, 1984; Wen et al., 1984; Wong & Raabe, 1989; Page & Mehlman, 1989). No statistically significant evidence was found in any study to link incidence of cancer of the kidney to work-place exposure to mixtures of complex hydrocarbons. Igimi et al. (1976) reported that d-limonene was a safe and effective gallstone solubilizer in animals and humans; side effects in humans were reported to be pain and tenderness radiating from the upper abdomen to the anterior chest, nausea and vomiting, and diarrhoea. 3. COMMENTS d-Limonene has been shown to reduce body weights significantly in male and female mice and rats and in female rabbits. The NOEL for this effect was 150 mg of d-limonene kg bw/day (administered by gavage) in a 2-year study in male rats. Oral administration of d-limonene (400 mg/kg bw/day) to rats for 20 days slightly increased liver weight and phospholipid content, decreased liver and serum cholesterol levels, increased the concentration of cytochromes P450 and B5, and increased the activities of aminopyrine demethylase and aniline hydroxylase. Although liver lesions were not associated with the administration of d-limonene in a 2-year study in rats (doses up to 150 mg/kg bw/day for males; doses up to 600 mg/kg bw/day for females), a daily gavage dose of 500 mg d-limonene/kg bw/day for 2 years was associated with an increased incidence of multinucleated liver hepatocytes and cytomegaly in male mice. The NOEL for these effects was 250 mg/kg bw/day administered by gavage to male mice for 2 years. Dermal application of d-limonene has been reported to cause irritation and immune-mediated skin reactions in a number of species, including humans. Oral administration of d-limonene to mice was reported to have immunological effects, including suppression of the in vitro mitogenic response by mouse T-cells and B-cells and both suppression and stimulation of antigenic responses. However, the biological significance of these in vitro changes is not known. Results of teratogenicity studies in mice suggest that maternal consumption of 2400 mg of d-limonene/kg bw/day but not of 600 mg/kg bw/day, affected the development of fetuses (decreased body weight gain, increased incidences of lumbar rib and fused rib, and delayed ossification). However, d-limonene was reported to be non-teratogenic in rabbits at doses ranging from 250 to 1000 mg/kg bw/day (although the highest dose significantly reduced survival of the dams). d-Limonene consistently produced negative results in genotoxicity studies, has been reported to inhibit the activity of other mutagens and carcinogens, and gave mixed responses in tumour-promotion studies. Data clearly demonstrate that d-limonene exacerbates the spontaneously occurring nephropathy in mature male rats which, after prolonged exposure, is associated with an increase in the incidence of renal tumours that are not commonly observed in control male rats. However, d-limonene is not the only substance that has this effect: various hydrocarbon mixtures and several other chemicals have also been reported to exacerbate spontaneous nephropathy and cause renal tumours in male rats. Although, in studies designed to elucidate the mechanism of this carcinogenic process, chemicals other than d-limonene were generally used as test substances, such studies have shown that the following mechanism is likely to be applicable to d-limonene-induced nephropathy and renal tumours in male rats: (1) d-limonene and d-limonene-1,2-oxide (a metabolite of d-limonene) bind reversibly to alpha2u-globulin in the kidneys of d-limonene-treated male rats; (2) this binding further slows down the normally slow processing of reabsorbed alpha2u-globulin; and (3) as a result, alpha2u-globulin accumulates in the phagolysosomes (hyaline droplets) of epithelial cells of the proximal convoluted tubules of the kidney, leading to necrosis, accumulation of cell debris, and regenerative hyperplasia. The postulated mechanism of action for some non-genotoxic carcinogens suggests that regenerative hyperplasia may increase clonal expansion of spontaneously initiated cells and lead to the development of the renal tumours observed. A NOEL for the d-limonene-associated increase in alpha2u-globulin levels in male rat kidney has not been identified, but the lowest-observed-effect level from a 21-day gavage study of d-limonene in male rats was 75 mg/kg bw/day. A sex-specific protein with molecular features similar to alpha2u-globulin has been identified in human urine, but the concentration is at least four orders of magnitude less than that of alpha2u-globulin in male rats. The Committee concluded that the postulated mechanism for d-limonene-induced nephropathy and renal tumours in the male rat was probably not relevant to humans, and that toxic end points associated with this effect were not appropriate bases for the derivation of an ADI for d-limonene. 4. EVALUATION Based on the significant decreases in body weight gain associated with administration of d-limonene to male and female mice and rats and female rabbits, an ADI of 0-1.5 mg/kg bw was established for this substance. The Committee considered the known natural occurrence and food additive uses of d-limonene, and concluded that only a small proportion of total intake is likely to be derived from direct additive use. The Committee therefore recommended that food additive intake be restricted to 75 µg/kg bw/day, which represents 5% of the maximum ADI for d-limonene. 5. REFERENCES ABRAMOVICI, A. & RACHMUTH-ROIZMAN, P. (1983). Molecular structure-teratogenicity relationships of some fragrance additives. Toxicology, 29: 143-156. ALDEN, C.L., KANERVA, R.L., RIDDER, G. & STONE, L.C. (1984). Chapter VIII: The pathogenesis of the nephrotoxicity of volatile hydrocarbons in the male rat. In: Advances in Modern Environmental Toxicology, Renal Effects of Petroleum Hydrocarbons, M.A. Mehlman, editor, pp. 107-120, Princeton Scientific, Princeton, NJ. ALDEN, C.L. (1989) Male rat specific alpha2u-globulin nephropathy and renal tumorigenesis. In: Bach, P.H. & Lock, E.A. (eds.), Handbook of Toxicologic Pathology. Academic Press, New York. In press (cited in US EPA 1991). ARIYOSHI, T., ARAKAKI, M., IDEGUCHI, K., ISHIZUKA, Y., NODA, K. & IDE, H. (1975). Studies on the metabolism of d-limonene (p-mentha-1,8-diene); III. Effects of d-limonene on the lipids and drug metabolizing enzymes in rat livers. Xenobiotica, 5: 33-38. AUSTIN, S.G. & SCHNATTER, A.R. (1983). A cohort mortality study of petrochemical workers. Journal of Occupational Medicine, 25: 304-312. BARBIER, P. & BENEZRA, C. (1983) The influence on induced hypersensitivity to citral in guinea-pigs; II. Label distribution in the skin of 14C-labelled citral. Acta Dermatovener (Stockholm), 63: 93-96. BERNARD, A.M., LAUWERYS, R.R., NOEL, A., VANDELEENE, B. & LAMBERT, A. (1989). Urine protein I: a sex-dependent marker of tubular or glomerular dysfunction. Clin. Chem., 35: 2141-2. BORGHOFF, S.J., SHORT, B.G., & SWENBERG, J.A. (1990) Biochemical mechanisms and pathobiology of alpha2u-globulin nephropathy. Ann. Rev. Pharmacol. Toxicol., 30: 349-367. BRUNER, R.H. (1984). Chapter X: Pathologic findings in laboratory animals exposed to hydrocarbon fuels of military interest. In: Advances in Modern Environmental Toxicology, Renal Effects of Petroleum Hydrocarbons, M.A. Mehlman, editor, pp. 133-140, Princeton Scientific, Princeton, NJ. BUSEY, W.M. & COCKRELL, B.Y. (1984). Chapter IV: Non-neoplastic exposure-related renal lesions in rats following inhalation of unleaded gasoline vapors. In: Advances in Modern Environmental Toxicology, Renal Effects of Petroleum Hydrocarbons, M.A. Mehlman, editor, pp. 57-64, Princeton Scientific, Princeton, NJ. CARPENTER, C.P., KINKEAD, E.R., GEARY, Jr., D.L., SULLIVAN, L.J. & KING, J.M. (1975a). Petroleum hydrocarbon toxicity studies: III. Animal and human response to vapors of Stoddard solvent. Toxicology and Applied Pharmacology, 32: 282-297. CARPENTER, C.P., KINKEAD, E.R., GEARY, Jr., D.L., SULLIVAN, L.J. & KING, J.M. (1975b). Petroleum hydrocarbon toxicity studies: VI. Animal and human responses to vapors of "60 solvent." Toxicology and Applied Pharmacology, 32: 374-394. CARPENTER, C.P., KINKEAD, E.R., GEARY, Jr., D.L., SULLIVAN, L.J. & KING, J.M. (1975c). Petroleum hydrocarbon toxicity studies: VI. Animal and human responses to vapors of "70 solvent." Toxicology and Applied Pharmacology, 34: 395-412. CARPENTER, C.P., GEARY, JR., D.L., MYERS, R.C., NACHREINER, D.J., SULLIVAN, L.J. & KING, J.M. (1977). Petroleum hydrocarbon toxicity studies: XV. Animal and human responses to vapors of "high naphthenic solvent." Toxicology and Applied Pharmacology, 41: 251-260. CHARBONNEAU, M., LOCK, E.A., STRASSER, J., COX, M.G., TURNER, M.J. & BUS, J.S. (1987). 2,2,4-trimethylpentane-induced nephrotoxicity: I. Metabolic disposition of TMP in male and female Fischer 344 rats. Toxicology and Applied Pharmacology, 91: 171-181. CHARBONNEAU, M., STRASSER, J., LOCK, E.A., TURNER, M.J. & SWENBERG, J.A. (1989). Involvement of reversible binding to alpha2u-globulin in 1,4-dichlorobenzene-induced nephrotoxicity. Toxicology and Applied Pharmacology, 99: 122-132. CHARBONNEAU, M. & SWENBERG, J.A. (1988). Studies on the bio-chemical mechanism of alpha2u-globulin nephropathy in rats. CIIT Activities, 8: 1-5. CURVALL, M., ENZELL, C. & PETTERSSON, B. (1984). An evaluation of the utility of four in vitro short-term tests for predicting the cytotoxicity of individual compounds derived from tobacco smoke. Cell Biology and Toxicology, 1: 173-193. DIETRICH, D.R. & SWENBERG, J.A. (1991). NCI-Black-Reiter (NBR) male rats fail to develop renal disease following exposure to agents that induce alpha2u-globulin nephropathy. Fundamentals of Applied Toxicology, 16: 749-762. DE GROOT, A.C., LIEM, D.H., NATER, J.P. & VAN KETEL, W.G. (1985). Patch tests with fragrance materials and preservatives. Contact Dermatitis, 12: 87-92. ELEGBEDE, J.A., ELSON, C.E., QURESHI, A., TANNER, M.A. & GOULD, M.N. (1984a). Inhibition of DMBA-induced mammary cancer by the monoterpene d-limonene. Carcinogenesis, 5: 661-664. ELEGBEDE, J.A., ELSON, C.E., QURESHI, A., TANNER, M.A. & GOULD, M.N. (1984b). Inhibition of DMBA-induced mammary cancer by the monoterpene d-limonene. Proceedings of the American Association of Cancer Researchers, 25: 127A. ELEGBEDE, J.A., ELSON, C.E., TANNER, M.A., QURESHI, A. & GOULD, M.N. (1986a). Regression of rat primary mammary tumours following dietary d-limonene. Journal of the National Cancer Institute, 76: 323-325. ELEGBEDE, J.A., MALTZMAN, T.H., VERMA, A.K., TANNER, M.A., ELSON, C.E. & GOULD, M.N. (1986b). Mouse skin tumour promoting activity of orange peel oil and d-limonene: a re-evaluation. Carcinogenesis, 7: 2047-2049. ELSON, C.E., MALTZMAN, T.H., BOSTON, J.L., TANNER, M.A. & GOULD, M.N. (1988). Anti-carcinogenic activity of d-limonene during the initiation and promotion/progression stages of DMBA-induced rat mammary carcinogenesis. Carcinogenesis, 9: 331-332. FAHRIG, R. (1984). Genetic mode of action of cocarcinogens and promoters in yeast and mice. Molecular and General Genetics, 194: 7-14. FLAMM, W.G. & LEHMAN-McKEEMAN, L. (1991). The human relevance of the renal tumour-inducing potential of d-limonene in male rats: Implications for risk assessment. Regulatory Toxicology and Pharmacology, 13: 70-86. FLORIN, I., RUTBERG, L., CURVALL, M. & ENZELL, C. (1980). Screening of tobacco smoke constituents for mutagenicity using the Ames test. Toxicology, 18: 219-232. GAD, S.C., DUNN, B.J., DOBBS, D.W., REILLY, C. & WALSH R.D. (1986). Development and validation of an alternative dermal sensitization test: the mouse ear swelling test (MEST). Toxicology and Applied Pharmacology, 84: 93-114. GARG, B.D., OLSON, M.J., DEMYAN, W.F. & ROY, A.K. (1988a). Rapid post-exposure decay of alpha2u-globulin and hyaline droplets in the kidneys of gasoline-treated male rats. Journal of Toxicology and Environmental Health, 24: 145-160. GARG, B.D., OLSON, M.J., MANCINI, M.A. & ROY, A.K. (1988b). Localization of alpha2u-globulin in hyaline droplets (phagolysosomes) of the male rat renal cortex by immunohistochemical techniques. Journal of Histochemistry and Cytochemistry, 36: 960. GARG, B.D., OLSON, M.J., LI, L.C. & ROY, A.K. (1989). Phagolysosomal alterations induced by unleaded gasoline in epithelial cells of the proximal convoluted tubules of male rats: Effect of dose and treatment duration. Journal of Toxicology and Environmental Health, 26: 101-118. GAWORSKI, C.L., HAUN, C.C. & MacEWEN, J.D. (1981). A ninety-day inhalation toxicity study of decalin. The Toxicologist, 1, 76. GAWORSKI, C.L., LEAHY, H.F. & BRUNER, H.F. (1980). Subchronic inhalation toxicity of decalin, Proceedings of the Tenth Conference on Environmental Toxicology, AFAMRL-TR-79-121 (ADA086341) Aerospace Medical Research Laboratory, Wright-Patterson Air Force Base, OH. GOLDSWORTHY, T.L., LYGHT, O., BURNETT, V.L. & POPP, J.A. (1988). Potential role of alpha2u-globulin, protein droplet accumulation, and cell replication in the renal carcinogenicity of rats exposed to trichloroethylene, perchloroethylene, and pentachloroethane. Toxicology and Applied Pharmacology, 96: 367-379. GOZSY, B. & KATO, L. (1957). Action of reticulo-endothelial-system stimulators on the histamine depleted rats. Arch. Int. Pharmacodyn, CXII: 235-246. GOZSY, B. & KATO, L. (1958). Reticulo-endothelial system stimulating compounds and their mechanism of action. Can. J. Biochem. Physiol., 36: 319-326. GREEN, T., ODUM, J., NASH, J.A. & FOSTER, J.R. (1990). Perchloroethylene-induced rat kidney tumours: An investigation of the mechanisms involved and their relevance to humans. Toxicol. Appl. Pharmacol., 102: 77-89. GREIF, N. (1967). Cutaneous safety of fragrance material as measured by the Maximization Test. American Perfumer and Cosmetics, 82: 54-57. HALDER, C.A., WARNE, T.M. & HATOUM, N.S. (1984). Chapter VI: Renal toxicity of gasoline and related petroleum naphthas in male rats. In: Advances in Modern Environmental Toxicology, Renal Effects of Petroleum Hydrocarbons, M.A. Mehlman, editor, pp. 73-88, Princeton Scientific, Princeton, NJ. HANAU, D., GROSSHANS, E., BARBIER, P. & BENEZRA, C. (1983). The influence of limonene on induced delayed hypersensitivity to citral in guinea-pigs; I. Histology study. Acta Dermatovener (Stockholm) 63: 1-7. HANIS, N.M., HOLMES, T.M., SHALLENBERGER, L.G. & JONES, K.E. (1982). Epidemiologic study of refinery and chemical plant workers. Journal of Occupational Medicine, 24: 203-212. HANIS, N.M., STRAVRAKY, K.M. & FOWLER, J.L. (1979). Cancer mortality in oil refinery workers. Journal of Occupational Medicine, 21: 167-174. HAWORTH, S., LAWLOR, T., MORTELMANS, K., SPECK, W. & ZEIGER, E. (1983). Salmonella mutagenicity test results for 250 chemicals. Environmental Mutagenesis Supplement, 1: 3-142. HECK, J.D., VOLLMUTH, T.A., CIFONE, M.A., JAGANNATH, D.R., MYHR, B. & CURREN, R.D. (1989). An evaluation of food flavoring ingredients in a genetic toxicity screening battery. The Toxicologist, 1: 257. HIGGINSON, J., MUIR, C. & BUFFLER, P.A. (1984). Chapter XV: The epidemiology of renal carcinoma in humans with a note on the effect of exposure to gasoline. In: Advances in Modern Environmental Toxicology, Renal Effects of Petroleum Hydrocarbons, M.A. Mehlman, editor, pp. 203-226, Princeton Scientific, Princeton, NJ. HOMBURGER, F., TREGER, A. & BOGER, E. (1971). Inhibition of murine subcutaneous and intravenous benzo(rst)pentaphene carcinogenesis by sweet orange oils and d-limonene. Oncology, 25: 1-10. IGIMI, H., HISATSUGU, T. & NISHIMURA, M. (1976). The use of d-limonene preparation as a dissolving agent of gallstones. Digestive Diseases, 21: 926-939. IGIMI, H., NISHIMURA, M., KODAMA, R. & IDE, H. (1974). Studies on the metabolism of d-limonene (p-mentha-1,8-diene): I. The absorption, distribution and excretion of d-limonene in rats. Xenobiotica, 4: 77-84. IMAIZUMI, K. HANADA, K., MAWATARI, K. & SUGANO, M. (1985). Effect of essential oils on the concentration of serum lipids and apolipoproteins in rats. Agric. Biol. Chem., 49: 2795-2796. KANERVA, R.L. & ALDEN, C.L. (1987). Review of kidney sections from a subchronic d-limonene oral dosing study conducted by the National Cancer Institute. Food and Chemical Toxicology, 25: 355-358. KANERVA, R.L., RIDDER, G.M., LEFEVER, F.R. & ALDEN, C.L. (1987a). Comparison of short-term renal effects due to oral administration of decalin or d-limonene in young adult male Fischer-344 rats. Food and Chemical Toxicology, 25: 345-353. KANERVA, R.L., MCCRACKEN, M.S., ALDEN, C.L. & STONE, L.C. (1987b). Morphogenesis of decalin-induced renal alterations in the male rat. Food and Chemical Toxicology, 25: 53-61. KANERVA, R.L., RIDDER, G.M., STONE, L.C. & ALDEN, C.L. (1987c). Characterization of spontaneous and decalin-induced hyaline droplets in kidneys of adult male rats. Food and Chemical Toxicology, 25: 63-82. KATO, L. & GOZSY, B. (1958). Treatment of experimental tuberculosis of the guinea-pig with dihydrostreptomycin and simultaneously with substances acting on the host. Arch. Int. Pharmacodyn, CXVII: 52-62. KITCHEN D.N. (1984). Chapter V: Neoplastic renal effects of unleaded gasoline in Fischer 344 rats. In: Advances in Modern Environmental Toxicology, Renal Effects of Petroleum Hydrocarbons, M.A. Mehlman, editor, pp. 65-88, Princeton Scientific, Princeton, NJ. KLECAK, G., GELEICK, H. & FREY, R. (1977). Screening of fragrance materials for allergenicity in the guinea-pig; comparison of four testing methods. J. Soc. Cosmet. Chem., 28: 53-64. KODAMA, R., NODA, K. & IDE, H. (1974). Studies on the metabolism of d-limonene (p-mentha-1,8-diene): II. The metabolic fate of d-limonene in rabbits. Xenobiotica, 4: 85-95. KODAMA, R., INOUE, H., NODA, K., IDE, H., YAMAMOTO, H., YOSHIHARA, S. & YOSHIMURA, H. (1976a). Effect of d-limonene and related compounds on bile flow and biliary lipid composition in rats and dogs. Life Sciences, 19: 1559-1568. KODAMA, R., YANO, T., FURUKAWA, K., NODA, K. & IDE, H. (1976b). Studies on the metabolism of d-limonene (p-mentha-1,8-diene): IV. Isolation and characterization of new metabolites and species differences in metabolism. Xenobiotica, 6: 377-389. KODAMA, R., OKUBO, A., ARAKI, E., NODA, K., IDE, H. & IKEDA, T. (1977a). Studies on d-limonene as a gallstone solubilizer; VII. Effects on development of mouse fetuses and offspring. Oyo Yakuri (Pharmacometrics) 13: 863-873. KODAMA, R., OKUBO, A., SATO, K., ARAKI, E., NODA, K., IDE, H. & IKEDA, T. (1977b). Studies on d-limonene as a gallstone solubilizer; IX. Effects on development of rabbit fetuses and offspring. Oyo Yakuri (Pharmacometrics), 13: 885-898. LEHMAN-McKEEMAN, L.D., CAUDILL, D., TAKIJIKU, R., SCHNEIDER, R.E. & YOUNG, J.A. (1990a). Comparative disposition of d-limonene in rats and mice: Relevance to male-rat-specific nephrotoxicity. Toxicol. Lett., 53: 193-195. LEHMAN-McKEEMAN, L.D., RIVERA-TORRES, M.I. & CAUDILL, D. (1990b). Lysosomal degradation of alpha2u-globulin and alpha2u-globulin-xenobiotic conjugates. Toxicology and Applied Pharmacology, 103: 539-548. LEHMAN-McKEEMAN, L.D., RODRIGUEZ, P.A., TAKIGIKU, R., CAUDILL, D. & FEY, M.L. (1989). d-Limonene-induced male rat-specific nephrotoxicity: Evaluation of the association between d-limonene and alpha2u-globulin. Toxicology and Applied Pharmacology, 99: 250-259. LOCK, E.A., CHARBONNEAU, M., STRASSER, J., SWENBERG, J.A. & BUS, J.S. (1987). 2,2,4-trimethylpentane-induced nephrotoxicity: II. The reversible binding of a TMP metabolite to a renal protein fraction containing alpha/2u-globulin. Toxicology and Applied Pharmacology, 91: 182-192. LOGOTHETOPOULOS, J. & WEINBREN, K. (1955). Naturally occurring protein droplets in the proximal tubule of the rat's kidney. British Journal of Experimental Pathology, 36: 402-406. LOURY, D.J., SMITH-OLIVER, T. & BUTTERWORTH, B.E. (1987). Assessment of the covalent binding potential of 2,2,4-trimethylpentane to rat alpha2u-globulin. Toxicology and Applied Pharmacology, 88: 44-56. MacEWEN, J.D. & VERNOT, E. (1978a). Evaluation of toxic effects of 90-day continuous exposure to conventional JP-5 jet fuel. In: Toxic Hazards Research Unit Annual Report, AFAMRL-TR-78-55 (ADA062138) Aerospace Medical Research Laboratory, Wright-Patterson Air Force Base, OH. MacEWEN, J.D. & VERNOT, E. (1978b). The effects of subchronic exposure of rodents to inhaled decalin. In: Toxic Hazards Research Unit Annual Report, AFAMRL-TR-78-55 (ADA062138) Aerospace Medical Research Laboratory, Wright-Patterson Air Force Base, OH. MacFARLAND, H.N., ULRICH, C.E., HOLDSWORTH, C.E., KITCHEN, D.N., HALLIWELL, W.H. & BLUM S.C. (1984). A chronic inhalation study with unleaded gasoline vapor. Journal of the American College of Toxicology, 3: 231-248. MacNAUGHTON, M.G. & UDDIN, D.E. (1984). Chapter IX: Toxicology of mixed distillate and high-energy synthetic fuels. In: Advances in Modern Environmental Toxicology, Renal Effects of Petroleum Hydrocarbons, M.A. Mehlman, editor, pp. 121-132, Princeton Scientific, Princeton, NJ. MALTZMAN, T.H., HURT, L.M., ELSON, C.E., TANNER, M.A. & GOULD, M.N. (1989). The prevention of nitrosomethylurea-induced mammary tumours by d-limonene and orange oil. Carcinogenesis, 10: 781-783. MEYER, F. & MEYER, E. (1959). Absorption of ethereal oils and substances contained in them through the skin. Arzneimittelforschung (Drug Research), 9: 516-519. MILLER, A.B., BOWEN, J.P., BORGHOFF, S.J. & SWENBERG, J.A. (1989). Computational and molecular modeling studies of alpha2u-globulin. Abstract papers of the American Chemical Society, 198: Medi-39. MURTY, C.V.R., OLSON, M.J., GARG, B.D. & ROY, A.K. (1988). Hydrocarbon-induced hyaline droplet nephropathy in male rats during senescence. Toxicology and Applied Pharmacology, 96: 380-392. NTP (1983). National Toxicology Program technical report on the toxicology and carcinogenesis studies of pentachloroethane (CAS No. 76-01-7) in F344/N rats and B6C3F1 mice (Gavage Studies), NTP TR 232, NIH Publication No. 83-1788. NTP (1986). National Toxicology Program technical report on the toxicology and carcinogenesis studies of 4-vinyl-cyclohexene (CAS No. 100-40-3) in F344/N rats and B6C3F1 mice (Gavage Studies), NTP TR 303, NIH Publication No. 86-2559. NTP (1987a). National Toxicology Program technical report on the toxicology and carcinogenesis studies of 1,4-di-chlorobenzene (CAS No. 106-46-7) in F344/N rats and B6C3F1 mice (Gavage Studies), NTP TR 319, NIH Publication No. 87-2570. NTP (1987b). National Toxicology Program technical report on the toxicology and carcinogenesis studies of dimethylmethylphosphonate (CAS No. 756-79-6) in F344/N rats and B6C3F1 mice (Gavage Studies), NTP TR 323, NIH Publication No. 88-2579. NTP (1990). National Toxicology Program technical report on the toxicology and carcinogenesis studies of d-limonene (CAS No. 5989-27-5) in F344/N rats and B6C3F1 mice (Gavage Studies), NTP TR 347, NIH Publication No. 90-2802. OLSON, C.T., YU, K.O. & SERVE, M.P. (1986). Metabolism of nephrotoxic cis- and trans-decalin in Fischer-344 rats. Journal of Toxicology and Environmental Health, 18: 285-292. OLSON, M.J., JOHNSON, J.T. & REIDY, C.A. (1990). A comparison of male rat and human urinary proteins: Implications for human resistance to hyaline droplet nephropathy. Toxicol. Appl. Pharmacol., 102: 524-536. OLSON, M.J., MANCINI, M.A., GARG, B.D. & ROY, A.K. (1988). Leupeptin-mediated alteration of renal phagolysosomes: Similarity to hyaline droplet nephropathy of male rats exposed to unleaded gasoline. Toxicol. Lett. 41: 245-254. OPDYKE, D.L.J. (1975). d-Limonene. Monograph on fragrance raw materials. Food and Cosmetics Toxicology, 13(suppl: 683-923): 825-826. PAGE, N.P. & MEHLMAN, M. (1989). Health effects of gasoline refueling vapors and measured exposures at service stations. Toxicology and Industrial Health, 5: 869-890. PARKER, G.A., BOGO, V. & YOUNG, R.W. (1981). Acute toxicity of conventional versus shale-derived JP5 jet fuel: Light microscopic, hematologic, and serum chemistry studies. Toxicology and Applied Pharmacology, 57: 302-317. PHILLIPS, R.D. & COCKRELL, B.Y. (1984). Chapter VII: Effect of certain light hydrocarbons on kidney function and structure in male rats. In: Advances in Modern Environmental Toxicology, Renal Effects of Petroleum Hydrocarbons, M.A. Mehlman, editor, pp. 89-105, Princeton Scientific, Princeton, NJ. PHILLIPS, R.D. & EGAN, G.F. (1984). Effect of C10-11 isoparaffinic solvent on kidney function in Fischer 344 rats during eight weeks of inhalation. Toxicology and Applied Pharmacology, 73: 500-510. PIRILA, V., SILTANEN, E. & PIRILA, L. (1964). On the chemical nature of the eczematogenic agent in oil of turpentine. Dermatologica, 128: 16-21. RAABE, G.K. (1984). Chapter XVIII: Kidney cancer epidemiology in petroleum related studies. In: Advances in Modern Environmental Toxicology, Renal Effects of Petroleum Hydrocarbons, M.A. Mehlman, editor, pp. 259-271, Princeton Scientific, Princeton, NJ. READ, N.G., ASTBURY, P.J., MORGAN, R.J.I., PARSONS, D.N. & PORT, C.J. (1988). Induction and exacerbation of hyaline droplet formation in the proximal tubular cells of the kidneys from male rats receiving a variety of pharmacological agents. Toxicology, 52: 81-101. RESEARCH INSTITUTE FOR FRAGRANCE MATERIALS, INC. (1985). Acute dermal irritation study; RIFM 1-32. RESEARCH INSTITUTE FOR FRAGRANCE MATERIALS, INC. (1990). The absorption, distribution, and excretion of radioactivity after topical application of 14C-limonene to rats. RESEARCH INSTITUTE FOR THE DEVELOPMENT OF FRAGRANCE MATERIALS, INC. (1984). Acute dermal irritation study; Ref. Nos. 307-338/8403. RIDDER, G.M., VON BARGEN, E.C., ALDEN, C.L. & PARKER, R.D. (1990). Increased hyaline droplet formation in male rats exposed to decalin is dependent on the presence of alpha2u-globulin. Fundamental and Applied Toxicology, 15: 732-743. ROE, F.J.C. (1959). Oil of sweet orange: A possible role in carcinogenesis. British Journal of Cancer, 13: 92-93. ROE, F.J.C. & Peirce, W.E.H. (1960). Tumour promotion by citrus oils: Tumours of the skin and urethral orifice in mice. Journal of the National Cancer Institute, 24: 1389-1403. ROY, A.K. & NEUHAUS, A.W. (1967) Androgenic control of a sex-dependent protein in the rat. Nature, 214: 618-20. SCHENK, J. DOBRONTE, Z., KOCH, H. & STOLTE, M. (1980). Untersuchungen zur gewebevertraglichkeit von d-limonen als einem losungsmittel cholesterineicher gallenstein. Gastroenterologie, 18: 389-394. SCHOTTENFELD, D., WARSHAUER, M.E., ZAUBER, A.G., MEIKLE, J.G. & HART, B.T. (1981). A prospective study of morbidity and mortality in petroleum industry employees in the United States - a preliminary report. In: Banbury Report 9: Quantification of Occupational Cancer, R. Peto & M. Schneiderman, editors, pp. 247-265. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. SHORT, G.B., BURNETT, V.L., COX, M.G., BUS, J.S. & SWENBERG, J.A. (1987). Site-specific renal cytotoxicity and cell proliferation in male rats exposed to petroleum hydrocarbons. Laboratory Investigation, 57: 564-577. SHORT, G.B., BURNETT, V.L. & SWENBERG, J.A. (1989a). Elevated proliferation of proximal tubule cells and localized accumulated alpha2u-globulin in F344 rats during chronic exposure to unleaded gasoline or 2,2,4-trimethylpentane. Toxicology and Applied Pharmacology, 101: 414-431. SHORT, G.B., STEINHAGEN, W.H. & SWENBERG, J.A. (1989b). Promoting effects of unleaded gasoline and 2,2,4-trimethylpentane on the development of atypical cell foci and renal tubular cell tumours in rats exposed to n-ethyl-n-hydroxyethylnitrosamine. Cancer Research, 49: 6369-6378. SHORT, G.B. & SWENBERG, J.A. (1988). Pathologic Investigations of the mechanism of unleaded gasoline-induced renal tumours in rats. CIIT Activities, 8: 1-6. STONARD, M.C., PHILLIPS, P.G.N., FOSTER, J.R., SIMPSON, M.G. & LOCK, E.A. (1986). Alpha2u-globulin: Measurement in rat kidney following administration of 2,2,4-trimethylpentane, Toxicology, 41: 161-168. STONE, L.C., KANERVA, R.L., BURNS, J.L. & ALDEN, C.L. (1987a). Decalin-induced nephrotoxicity: Light and electron microscopic examination of the effects of oral dosing on the development of kidney lesions in the rat. Food and Chemical Toxicology, 25: 43-52. STONE, L.C., McCRACKEN, M.S., KANERVA, R.L. & ALDEN, C.L. (1987b). Development of a short-term model of decalin inhalation nephrotoxicity in the male rat. Food and Chemical Toxicology, 25: 35-41. STONER, G.D., SHIMKIN, M.B., KNIAZEFF, A.J., WEISBURGER, J.H., WEISBURGER, E.K. & GORI, G.B. (1973). Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumour response in strain A mice. Cancer Research, 33: 3069-3085. SWENBERG, J.A. (1991). Editorial. Risk assessment of chemicals causing alpha2u-globulin nephropathy. Reg. Toxicol. Pharmacol., 13: 1-2. SWENBERG, J.A., SHORT, B., BORGHOFF, S., STRASSER, J. & CHARBONNEAU, M. (1989). The comparative pathobiology of alpha2u-globulin nephropathy. Toxicology and Applied Pharmacology, 97: 35-46. THELESTAM, M., CURVALL, M. & ENZELL, C. (1980). Effect of tobacco smoke compounds on the plasma membrane of cultured human lung fibroblasts. Toxicology, 15: 203-217. THOMAS, T.L., WAXWEILER, R.J., MOURE-ERASO, R., ITAYA, S. & FRAUMENI, Jr., J.F. (1982). Mortality patterns among workers in three Texas oil refineries. Journal of Occupational Medicine, 24: 135-141. TRUMP, B.F., BEREZESKY, I.K., SATO, K. & SAIKO, K.U. (1984). Cell calcium, cell injury, and cell death. Environ.Hlth. Revs., 57: 281-287. TSUJI, M., FUJISAKI, Y., YAMACHIKA, K. NAKAGAMI, K., FUJISAKI, F., MITO, M., AOKI, T., KINOSHITA, S., OKUBO, A. & WATANABE, I. (1974). Studies on d-limonene as gallstone solubilizer; I. General pharmacological studies. Oyo Yakuri (Pharmacometrics), 8: 1439-1459. TSUJI, M., FUJISAKI, Y., ARIKAWA, Y., MASUDA, S., KINOSHITA, S., OKUBO, A., NODA, K., IDE, H. & IWANAGA, Y. (1975a). Studies on d-limonene, as gallstone solubilizer (II): Acute and subacute toxicities. Oyo Yakuri (Pharmacometrics), 9: 387-401. US EPA (1991). Alpha2u-globulin: Association with chemically induced renal toxicity and neoplasia in the male rat. Risk Assessment Forum, US Environmental Protection Agency, Washington, DC, USA, EPA/625/3-91/019F. VAN DUUREN, B.L. & GOLDSCHMIDT, B.M. (1976). Co-carcinogenic and tumour-promoting agents in tobacco carcinogenesis. Journal of the National Cancer Institute, 56: 1237-1242. WADE, A.P., WILKINSON, G.S., DEAN, F.M. & PRICE, A.W. (1966). The isolation, characterization and structure of uroterpenol, a monoterpene from human urine. Biochem. J., 101: 727-734. WATABE, T., HIRATSUKA, A., ISOBE, M. & OZAWA, N. (1980). Metabolism of d-limonene by hepatic microsomes to non-mutagenic epoxides toward Salmonella typhimurium. Biochemical Pharmacology, 29: 1068-1071. WEBB, D.R., KANERVA, R.L., HYSELL, D.K., ALDEN, C.L. & LEHMAN-MCKEEMAN, L.D. (1990). Assessment of the subchronic oral toxicity of d-limonene in dogs. Fd. Chem. Toxic., 28: 669-675. WEBB, D.R., RIDDER, G.M. & ALDEN, C.L. (1989). Acute and subacute nephrotoxicity of d-limonene in Fischer 344 rats. Fd. Chem. Toxicol., 27: 639-649. WEN, C.P., ISAI, S.P., MOFFITT, K.B., BONDY, M. & GIBSON, R.L. (1984). Chapter XVII: Epidemiologic studies of the role of gasoline (hydrocarbon) exposure in kidney cancer risk. In: Advances in Modern Environmental Toxicology, Renal Effects of Petroleum Hydrocarbons, M.A. Mehlman, editor, pp. 245-257, Princeton Scientific, Princeton, NJ. WONG, O. & RAABE, G. (1989). Critical review of cancer epidemiology in petroleum industry employees, with a quantitative meta-analysis by cancer site. American Journal of Industrial Medicine, 15: 283-310.
See Also: Toxicological Abbreviations Limonene (CICADS 5, 1998)